PTE PolarityTE, Inc. Stock Quote

PTE [NASD]

Index	-	P/E	-	EPS (ttm)	-1.13	Insider Own	13.50%	Shs Outstand	80.59M	Perf Week	17.65%
Market Cap	91.42M	Forward P/E	-	EPS next Y	-0.51	Insider Trans	-0.68%	Shs Float	64.94M	Perf Month	17.65%
Income	-42.90M	PEG	-	EPS next Q	-0.12	Inst Own	14.80%	Short Float	6.92%	Perf Quarter	-6.98%
Sales	10.10M	P/S	9.05	EPS this Y	70.20%	Inst Trans	4.09%	Short Ratio	0.88	Perf Half Y	33.32%
Book/sh	0.61	P/B	1.97	EPS next Y	12.30%	ROA	-82.20%	Target Price	-	Perf Year	31.87%
Cash/sh	-	P/C	-	EPS next 5Y	15.00%	ROE	-139.20%	52W Range	0.55 - 2.38	Perf YTD	76.47%
Dividend	-	P/FCF	-	EPS past 5Y	25.10%	ROI	-143.10%	52W High	-49.58%	Beta	1.07
Dividend %	-	Quick Ratio	3.60	Sales past 5Y	45.70%	Gross Margin	56.30%	52W Low	117.00%	ATR	0.09
Employees	80	Current Ratio	3.70	Sales Q/Q	140.00%	Oper. Margin	-	RSI (14)	62.33	Volatility	9.51% 7.13%
Optionable	Yes	Debt/Eq	0.18	EPS Q/Q	71.30%	Profit Margin	-	Rel Volume	29.14	Prev Close	0.97
Shortable	Yes	LT Debt/Eq	0.08	Earnings	May 13 AMC	Payout	-	Avg Volume	5.10M	Price	1.20
Recom	2.30	SMA20	23.68%	SMA50	6.57%	SMA200	9.99%	Volume	114,871,000	Change	23.18%

May-01-20

Downgrade

Oppenheimer

Outperform → Perform

Nov-11-19

Resumed

Cantor Fitzgerald

Overweight

$50 → $13

Jul-08-19

Initiated

H.C. Wainwright

Buy

Mar-21-19

Initiated

Evercore ISI

Outperform

$26

Jan-28-19

Initiated

Northland Capital

Outperform

$50

Jan-28-19

Initiated

National Securities

Sell

Dec-20-18

Initiated

Piper Jaffray

Overweight

May-10-21 09:06AM	PolarityTE Stock Jumps As SkinTE Aces Diabetic Foot Ulcer Trial Benzinga +23.18%
08:00AM	PolarityTE Announces Diabetic Foot Ulcer Trial Met Primary and Secondary Endpoint Business Wire
May-03-21 03:01PM	PolarityTE, Inc. (PTE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
08:00AM	PolarityTE to Report First Quarter Financial Results on May 13, 2021 Business Wire
Apr-07-21 07:47AM	Is the Options Market Predicting a Spike in PolarityTE (PTE) Stock? Zacks -8.04%
Mar-30-21 07:00AM	PolarityTE Reports Fourth Quarter and Fiscal Year 2020 Results Business Wire
06:15AM	PolarityTE, Inc. to Host Earnings Call ACCESSWIRE
Mar-29-21 10:07AM	PolarityTE's Earnings Outlook Benzinga +10.81%
Mar-23-21 12:30PM	PolarityTE, Inc. (PTE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks -9.09%
Mar-10-21 08:00AM	PolarityTE to Report Fiscal Year 2020 Financial Results on March 30, 2021 Business Wire -7.91%
Mar-04-21 12:30PM	PolarityTE, Inc. (PTE) May Report Negative Earnings: Know the Trend Ahead of Q4 Release Zacks -7.91%
Mar-02-21 08:00AM	PolarityTE to Present at the H.C. Wainwright Global Life Sciences Virtual Conference Business Wire +9.77%
Feb-19-21 06:10AM	What Percentage Of PolarityTE, Inc. (NASDAQ:PTE) Shares Do Insiders Own? Simply Wall St.
Feb-10-21 08:00AM	PolarityTE Provides Corporate Update Business Wire +6.49%
Feb-03-21 04:15PM	PolarityTE Receives Allowance for Additional U.S. Patent Business Wire +18.75%
Jan-22-21 08:45AM	PolarityTE, Inc. Announces Exercise of Warrants for Gross Proceeds of $7.67 Million Business Wire
Jan-21-21 08:00AM	PolarityTE Announces Completion of Target Enrollment in Diabetic Foot Ulcer Trial Business Wire
Jan-14-21 04:05PM	PolarityTE Announces Closing of $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Business Wire +5.22%
Jan-12-21 07:00AM	PolarityTE Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Business Wire -11.20%
Jan-11-21 08:50AM	Do Options Traders Know Something About PolarityTE (PTE) Stock We Don't? Zacks -5.30%
08:00AM	PolarityTE Announces Formation of Strategic Review Committee Business Wire
Jan-08-21 11:54AM	PTE Stock Alert: 7 Things for Investors to Know About PolarityTE as Shares Soar InvestorPlace +72.17%
10:21AM	Looking Into PolarityTE's Return On Capital Employed Benzinga
Jan-05-21 08:00AM	PolarityTE to Present at the H.C. Wainwright Virtual Bioconnect 2021 Conference Business Wire +6.74%
Dec-22-20 08:00AM	PolarityTE Announces $8.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Business Wire
Dec-07-20 10:22PM	Is PTE A Good Stock To Buy Now? Insider Monkey
Nov-30-20 08:00AM	PolarityTE Receives Allowance for First U.S. Patent Business Wire
Nov-24-20 08:00AM	PolarityTE Announces Dismissal of Securities Class Action Complaint with Prejudice Business Wire
Nov-09-20 07:24AM	Recap: PolarityTE Q3 Earnings Benzinga -15.37%
07:00AM	PolarityTE Reports Third Quarter 2020 Results Business Wire
Nov-02-20 08:00AM	PolarityTE Announces Successful Completion of Initial Pre-IND Interaction with U.S. Food and Drug Administration for SkinTE® Business Wire
Oct-26-20 08:00AM	PolarityTE to Report Third Quarter 2020 Financial Results on November 9, 2020 Business Wire +13.06%
Sep-29-20 08:00AM	PolarityTE Announces Termination of Shareholder Rights Plan Business Wire
Sep-21-20 08:00AM	PolarityTE Receives NIH Grant for a Point-of-Care Device to Treat Chronic Wounds Business Wire
Sep-16-20 08:00AM	SkinTE Health EconomicsDFU Interim Analysis Data Demonstrates Potential for Cost Savings and Improved Wound Closure Business Wire
Sep-14-20 08:00AM	PolarityTE Expects Third Quarter Revenue to Meet or Exceed High-End of Guidance Business Wire
Sep-10-20 08:00AM	PolarityTE to Present at H.C. Wainwright 22nd Annual Global Investment Conference and Cantor Virtual Global Healthcare Conference Business Wire
Sep-08-20 08:00AM	PolarityTE Announces Strategic Partnership with Co-Diagnostics to Expand COVID-19 Testing Platform Business Wire +13.46%
08:00AM	Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services PR Newswire
Aug-06-20 07:00AM	PolarityTE Reports Second Quarter 2020 Results Business Wire
Jul-30-20 08:00AM	PolarityTE Announces the Addition of Clinical Development and Regulatory Affairs Executive Jessica Shen, MD, MS to Board of Directors Business Wire
Jul-29-20 08:00AM	PolarityTE to Report Second Quarter 2020 Financial Results on August 6, 2020 Business Wire -5.73%
Jul-24-20 08:00AM	PolarityTE Announces Positive Top-Line Data from Interim Analysis of SkinTE Diabetic Foot Ulcer Trial Business Wire +10.56%
Jul-20-20 08:00AM	PolarityTE Announces Interim Data from Diabetic Foot Ulcer Trial will be Presented at Symposium on Advanced Wound Care to be Held July 24-26, 2020 Business Wire +27.59%
Jul-05-20 08:50PM	Should You Buy PolarityTE, Inc. (PTE)? Insider Monkey
Jun-10-20 07:52AM	Rising P/E: An Overlooked Trick to Pick 5 Winning Stocks Zacks +27.93%
Jun-01-20 08:00AM	PolarityTETwo Peer-Reviewed Manuscripts Published on SkinTE Business Wire
May-27-20 11:29AM	Verscend Holding Corp. -- Moody's announces completion of a periodic review of ratings of Verscend Holding Corp. Moody's +14.52%
May-11-20 07:00AM	PolarityTE Reports First Quarter 2020 Results Business Wire
Apr-30-20 04:15PM	PolarityTE Provides Update on Corporate Strategy and Regulatory Pathway for SkinTE Business Wire -5.50%
Apr-21-20 08:00AM	PolarityTE Provides Corporate Update Related to COVID-19 and Announces Preliminary First Quarter Results Business Wire -7.96%
Apr-17-20 09:01AM	Do Options Traders Know Something About PolarityTE (PTE) Stock We Don't? Zacks +5.02%
Apr-13-20 08:00AM	PolarityTE Announces Data from Head-to-Head Burn Study Demonstrating Graft Take and Wound Closure with SkinTE Treatment Business Wire +6.72%
Apr-08-20 08:00AM	PolarityTE Announces Conclusion of SEC Investigation Business Wire +11.17%
Apr-06-20 08:00AM	PolarityTE Announces the Addition of Audit Executive Chris Nolet to Board of Directors Business Wire +5.54%
Apr-01-20 08:00AM	PolarityTE Announces Appointment of David Seaburg as CEO and Restructuring of Executive Team Business Wire -12.75%
Mar-15-20 09:26AM	Earnings Release: Here's Why Analysts Cut Their PolarityTE, Inc. Price Target To US$10.17 Simply Wall St.
Mar-12-20 07:00AM	PolarityTE Reports Fiscal Year 2019 Financial Results Business Wire -7.48%
Mar-05-20 08:00AM	PolarityTE to Attend the Oppenheimer 30th Annual Healthcare Conference Business Wire
Mar-03-20 08:00AM	PolarityTE to Report Fiscal Year 2019 Financial Results on March 12, 2020 Business Wire
Feb-18-20 06:38PM	Bragar Eagel & Squire is Investigating Certain Officers and Directors of PolarityTE, comScore, AMC, and Conagra Brands and Encourages Investors to Contact the Firm GlobeNewswire -5.92%
Feb-12-20 09:24AM	PolarityTE's stock loses nearly half its value after public offering of stocks, warrants MarketWatch -47.17%
09:00AM	PolarityTE Announces Pricing of Public Offering of Common Stock and Warrants Business Wire
Feb-11-20 04:01PM	PolarityTE Announces Public Offering of Common Stock and Warrants Business Wire
Dec-19-19 06:29PM	Hedge Funds Are Crazy About PolarityTE, Inc. (PTE) Insider Monkey
Dec-18-19 08:00AM	PolarityTE to Participate in Corporate Access Event in San Francisco, January 13-15, 2020 Business Wire
Dec-12-19 09:11AM	Is the Options Market Predicting a Spike in PolarityTE (PTE) Stock? Zacks
Dec-10-19 08:00AM	PolarityTE Builds Patent Portfolio with New International Patent Grants Business Wire
Dec-06-19 08:00AM	12 Biotech Stocks Primed For A Short Squeeze Benzinga +9.27%
Dec-05-19 08:00AM	PolarityTE Announces Equity Purchase Agreement for up to $25 Million with Keystone Capital Partners Business Wire -12.79%
Nov-28-19 09:42AM	Here's Why We're A Bit Worried About PolarityTE's (NASDAQ:PTE) Cash Burn Situation Simply Wall St.
Nov-27-19 08:00AM	PolarityTE to Attend Evercore ISI 2nd Annual HealthCONx Conference and Piper Jaffray 31st Annual Healthcare Conference TEST Business Wire Releases
08:00AM	PolarityTE to Attend Evercore ISI 2nd Annual HealthCONx Conference and Piper Jaffray 31st Annual Healthcare Conference Business Wire
Nov-19-19 04:55PM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PolarityTE, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Nov-12-19 04:05PM	PolarityTE Reports Third Calendar Quarter 2019 Results Business Wire -11.55%
Nov-07-19 04:01PM	PolarityTE Adopts Short-Term Shareholder Rights Plan Business Wire
Oct-24-19 08:00AM	PolarityTE to Report Calendar Third Quarter Financial Results on November 12, 2019 Business Wire -7.93%
Oct-14-19 03:36PM	PolarityTE, Inc. (NASDAQ:PTE): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
08:00AM	PolarityTE Announces Positive Pilot Study Data of SkinTE as a Treatment for Venous Stasis Leg Ulcers Business Wire
Oct-06-19 10:00AM	Bragar Eagel & Squire is Investigating Certain Officers and Directors of National General Holdings, Natural Health Trends, Omnicell, and Polarity TE and Encourages Investors to Contact the Firm GlobeNewswire
Oct-03-19 08:00AM	SkinTE Data to be Presented at the 19th Annual Diabetic Foot Global Conference Business Wire
Sep-26-19 08:00AM	PolarityTE Selected to Present at 2019 Cell & Gene Meeting on the Mesa Business Wire -8.98%
Sep-23-19 08:00AM	PolarityTE Announces Positive Data Showing SkinTE Regenerated Full-Thickness Skin in Difficult-to-Treat Wounds Business Wire +5.78%
Sep-18-19 08:00AM	PolarityTE to Attend the 2019 Cantor Global Healthcare Conference Business Wire
Sep-16-19 08:00AM	SkinTE Data Including Final Pilot Study Data Readout to be Presented at the Symposium on Advanced Wound Care Fall Meeting Business Wire
Sep-09-19 08:00AM	SkinTE Data to be Presented at the American Society of Plastic Surgeons 88th Annual Scientific Meeting PR Newswire +5.44%
Sep-04-19 08:00AM	PolarityTE Appoints Peter Cohen as Chairman of the Board PR Newswire +8.89%
Aug-28-19 08:00AM	PolarityTE to Attend H.C. Wainwright 21st Annual Healthcare Conference and Morgan Stanley 17th Annual Global Healthcare Conference PR Newswire +18.08%
Aug-20-19 01:43PM	Introducing PolarityTE (NASDAQ:PTE), The Stock That Tanked 80% Simply Wall St.
12:55PM	PolarityTE Granted Canadian Patent PR Newswire
Aug-16-19 08:00AM	PolarityTE to Present at Military Health System Research Symposium on Platform Technology for Treatment of Traumatic and Chronic Wounds PR Newswire
Aug-08-19 07:00AM	PolarityTE Reports Second Calendar Quarter 2019 Results PR Newswire +19.44%
Jul-25-19 08:00AM	PolarityTE to Report Calendar Second Quarter Financial Results on August 8, 2019 PR Newswire
Jul-24-19 09:35AM	PolarityTE Enters Oversold Territory Zacks
Jun-29-19 07:17PM	Is PolarityTE, Inc. (PTE) A Good Stock To Buy ? Insider Monkey
Jun-19-19 12:30PM	What Type Of Shareholder Owns PolarityTE, Inc.'s (NASDAQ:PTE)? Simply Wall St.
Jun-12-19 11:49AM	Weekly CFO Buys Highlight GuruFocus.com
Jun-10-19 10:09AM	PolarityTE Shares Rally On Positive Readout From Skin Graft Study In Diabetic Foot Ulcers Benzinga
08:00AM	PolarityTE Announces Final Clinical Data from Pilot Study Showing Closure of Diabetic Foot Ulcers Using SkinTE PR Newswire
Jun-08-19 05:38PM	Ready Trader One: Events, Stocks To Watch At E3 Benzinga

PolarityTE, Inc., a biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates through two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and OsteoTE. PolarityTE, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Seaburg David B	Chief Executive Officer	Apr 19	Sale	0.86	31,031	26,842	1,129,813	Apr 21 04:30 PM
Lough Denver	Prior Director and Officer	Mar 01	Option Exercise	0.00	11,112	0	7,209,561	Mar 03 04:05 PM
Lough Denver	Prior Director and Officer	Feb 01	Option Exercise	0.00	11,111	0	7,201,511	Feb 03 04:10 PM
Seaburg David B	Chief Executive Officer	Jan 19	Sale	1.09	31,037	33,986	880,240	Jan 21 04:15 PM
Lough Denver	Prior Director and Officer	Jan 04	Option Exercise	0.00	11,111	0	7,193,911	Jan 06 04:05 PM
Seaburg David B	Chief Executive Officer	Dec 30	Sale	0.67	8,515	5,714	911,277	Dec 31 04:05 PM
Lough Denver	Prior Director and Officer	Dec 01	Option Exercise	0.00	11,111	0	7,187,742	Dec 03 04:05 PM
Lough Denver	Prior Director and Officer	Nov 01	Option Exercise	0.00	11,111	0	7,181,889	Nov 04 04:05 PM
Seaburg David B	Chief Executive Officer	Oct 19	Sale	1.02	31,032	31,560	919,792	Oct 20 04:05 PM
Hoyler Cameron J.	Gen. Counsel & Exec. VP	Oct 19	Sale	1.03	9,999	10,299	587,438	Oct 20 04:05 PM
Lough Denver	Prior Director and Officer	Oct 01	Option Exercise	0.00	11,111	0	7,174,079	Oct 05 04:05 PM
Seaburg David B	Chief Executive Officer	Sep 30	Sale	1.03	8,514	8,795	950,824	Oct 01 05:29 PM
Hoyler Cameron J.	Gen. Counsel & Exec. VP	Sep 29	Sale	1.01	936	945	597,437	Sep 30 04:05 PM
Hoyler Cameron J.	Gen. Counsel & Exec. VP	Sep 22	Sale	1.02	3,500	3,570	598,373	Sep 23 04:05 PM
Seaburg David B	Chief Executive Officer	Sep 02	Sale	1.13	5,600	6,306	959,338	Sep 04 04:05 PM
Lough Denver	Prior Director and Officer	Sep 01	Option Exercise	0.00	11,111	0	7,166,447	Sep 03 04:05 PM
Dyer Jeffrey Hansen	Director	Aug 24	Sale	1.27	1,000	1,271	53,286	Aug 25 05:00 PM
Hoyler Cameron J.	Gen. Counsel & Exec. VP	Aug 07	Sale	1.53	11,667	17,851	601,873	Aug 10 04:05 PM
Seaburg David B	Chief Executive Officer	Aug 07	Sale	1.53	16,334	24,991	964,938	Aug 10 04:06 PM
Lough Denver	Prior Director and Officer	Aug 03	Option Exercise	0.00	11,111	0	7,158,530	Aug 05 10:56 AM
Lough Denver	Prior Director and Officer	Jul 01	Option Exercise	0.00	11,111	0	7,150,671	Jul 06 11:11 AM
Seaburg David B	Chief Executive Officer	Jul 01	Sale	1.28	8,514	10,881	1,002,451	Jul 02 04:06 PM
Hoyler Cameron J.	Gen. Counsel & Exec. VP	Jun 29	Sale	1.44	936	1,348	622,184	Jun 30 04:05 PM
Lough Denver	Prior Director and Officer	Jun 01	Option Exercise	0.00	11,112	0	7,139,560	Jun 03 11:07 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience